4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001415889-24-026737
Chief Executive Officer sold 2,500 shares at $7.82 ($19,557)
- Chief Executive Officer acquired 2,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Townsend Richard Nolan Chief Executive Officer | 2024-11-11 | Option exercise 10b5-1 | +2,500 | $2.33 | $5,825 | 123,195 | D |
| Townsend Richard Nolan Chief Executive Officer | 2024-11-11 | Sale 10b5-1 | −2,500 | $7.82 | $19,557 | 120,695 | D |
| Derivatives | |||||||
| Townsend Richard Nolan Chief Executive Officer | 2024-11-11 | Option exercise · Stock Option (right to buy) 10b5-1 | −2,500 | 121,155 | D | ||
| Open-market sales · 2,500 sh · avg $7.82 · $19,557 | |||||||
Loading xslF345X05/form4-11132024_101126.xml…